Zhejiang Chemsyn Pharm CoBJSE:920656 36 OCF Margin % is 6.83% as of Mar. 2026, which is 65% below its 10-year median of 19.70. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 77.78% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920656 vs UNH, CVS, ELV: OCF Margin % Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co OCF Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a OCF Margin % of 6.83% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 65% below median its historical median of 19.70. Over the past decade, Zhejiang Chemsyn Pharm Co's OCF Margin % has ranged from 3.55 to 46.30. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #4 out of 18 companies in the Healthcare Plans industry, placing it in the top 22.2%.
Is Zhejiang Chemsyn Pharm Co's OCF Margin % too high?
Zhejiang Chemsyn Pharm Co's current OCF Margin % of 6.83% is 65% below median its 10-year median of 19.70. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 46.30. The Healthcare Plans industry median OCF Margin % is 5.53. Zhejiang Chemsyn Pharm Co's value of 6.83% is 23.6% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #4 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's OCF Margin % compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #4 out of 18 companies for OCF Margin %. This places Zhejiang Chemsyn Pharm Co in the top 22% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.53. Zhejiang Chemsyn Pharm Co's value of 6.83% is 23.6% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own OCF Margin % has ranged from 3.55 to 46.30 over the past decade. While the company's 10-year median is 19.70 vs. the industry median of 5.53, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Plans company?
The median OCF Margin % among Healthcare Plans companies is 5.53, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current OCF Margin % of 6.83% is 23.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median OCF Margin % is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current OCF Margin % is 6.83%, which is 65% below median its own 10-year median of 19.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current OCF Margin % of 6.83%. The current OCF Margin % is 6.83%, which is 65% below median its 10-year median of 19.70 and 23.6% above the Healthcare Plans industry median of 5.53. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current OCF Margin % is 6.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
